NEWTON, Mass.--(BUSINESS WIRE)--April 10, 2006--Pro-Pharmaceuticals, Inc. (Amex: PRW - News), a developer of novel carbohydrate-based therapeutic compounds, today announced the nomination of Dr. Henry Esber to its Board of Directors. Dr. Esber will stand for election by the Company’s stockholders at the upcoming Annual Meeting to be held on May 25, in Newton, Massachusetts.
